Dyne Therapeutics Inc (DYN) is a Healthcare · Biotechnology company listed on NASDAQ. Price $17.11 (-5.26%), Market cap $2.86B, 52-week low–high $8.18 ~ $24.29.
Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. The company is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. Dyne Therapeutics, Inc. was incorporated in 2017 and is headquartered in Waltham, Massachusetts.
Financial statements, price targets, institutional (13F) holdings and related news for Dyne Therapeutics Inc are updated in real time on BlackAll Trade.
Dyne Therapeutics Inc trades at $17.11 (-5.26%). Real-time quotes and charts are available on BlackAll Trade.
Dyne Therapeutics Inc has a market cap of about $2.86B.
Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. The company is developing a